AMAN GBS Variant — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Acute motor axonal neuropathy (AMAN) — the axonal variant of GBS, strongly associated with preceding C. jejuni infection and anti-GM1 ganglioside antibodies
AMAN is an axonal variant of GBS characterised by pure motor involvement with axonal degeneration (not demyelination) on NCS. It is strongly associated with preceding C. jejuni infection and anti-GM1/anti-GD1a ganglioside antibodies. It is more common in Asia and Central America than in Europe (where AIDP predominates). Treatment is the same as for AIDP (IVIG or plasma exchange). Recovery may be slower than demyelinating GBS due to axonal damage requiring nerve regeneration. Miller Fisher syndrome (ataxia, ophthalmoplegia, areflexia) is associated with anti-GQ1b antibodies.
Reference: NICE NG220 2022 – GBS; Lancet Neurol 2019 – GBS variants